598 related articles for article (PubMed ID: 8962129)
1. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129
[TBL] [Abstract][Full Text] [Related]
2. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
[TBL] [Abstract][Full Text] [Related]
3. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.
Fukumura D; Yuan F; Monsky WL; Chen Y; Jain RK
Am J Pathol; 1997 Sep; 151(3):679-88. PubMed ID: 9284816
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
5. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.
Kondo S; Asano M; Suzuki H
Biochem Biophys Res Commun; 1993 Aug; 194(3):1234-41. PubMed ID: 7688963
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
Asano M; Yukita A; Matsumoto T; Kondo S; Suzuki H
Cancer Res; 1995 Nov; 55(22):5296-301. PubMed ID: 7585591
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF
Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760
[TBL] [Abstract][Full Text] [Related]
8. Effect of local anti-VEGF antibody treatment on tumor microvessel permeability.
Lichtenbeld HC; Ferarra N; Jain RK; Munn LL
Microvasc Res; 1999 May; 57(3):357-62. PubMed ID: 10329263
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
Luo JC; Toyoda M; Shibuya M
Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
[TBL] [Abstract][Full Text] [Related]
10. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
11. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak HF; Brown LF; Detmar M; Dvorak AM
Am J Pathol; 1995 May; 146(5):1029-39. PubMed ID: 7538264
[TBL] [Abstract][Full Text] [Related]
12. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.
Dvorak HF; Sioussat TM; Brown LF; Berse B; Nagy JA; Sotrel A; Manseau EJ; Van de Water L; Senger DR
J Exp Med; 1991 Nov; 174(5):1275-8. PubMed ID: 1940805
[TBL] [Abstract][Full Text] [Related]
13. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?
Weindel K; Moringlane JR; Marmé D; Weich HA
Neurosurgery; 1994 Sep; 35(3):439-48; discussion 448-9. PubMed ID: 7528359
[TBL] [Abstract][Full Text] [Related]
15. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
EXS; 1997; 79():233-69. PubMed ID: 9002222
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.
Monsky WL; Fukumura D; Gohongi T; Ancukiewcz M; Weich HA; Torchilin VP; Yuan F; Jain RK
Cancer Res; 1999 Aug; 59(16):4129-35. PubMed ID: 10463618
[TBL] [Abstract][Full Text] [Related]
17. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.
Sundberg C; Nagy JA; Brown LF; Feng D; Eckelhoefer IA; Manseau EJ; Dvorak AM; Dvorak HF
Am J Pathol; 2001 Mar; 158(3):1145-60. PubMed ID: 11238063
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium.
Qu-Hong ; Nagy JA; Senger DR; Dvorak HF; Dvorak AM
J Histochem Cytochem; 1995 Apr; 43(4):381-9. PubMed ID: 7534783
[TBL] [Abstract][Full Text] [Related]
19. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
20. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
